Renovion, Inc.

Dr. Robert Ryan Joins Renovion, Inc. Board of Directors

LogoRenovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung transplant patients, cystic fibrosis (CF), and chronic obstructive pulmonary disorder (COPD), announced today that Dr Robert Ryan has joined the Board of Directors for the company.